Boston Scientific

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BSX and other ETFs, options, and stocks.

About BSX

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
41,000
Employees41,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
41,000
Employees41,000

BSX Key Statistics

Market cap
68.00B
Market cap68.00B
Price-Earnings ratio
112.26
Price-Earnings ratio112.26
Dividend yield
Dividend yield
Average volume
5.12M
Average volume5.12M
High today
$46.76
High today$46.76
Low today
$45.65
Low today$45.65
Open price
$45.75
Open price$45.75
Volume
7.15M
Volume7.15M
52 Week high
$47.50
52 Week high$47.50
52 Week low
$34.98
52 Week low$34.98

BSX News

Benzinga 2d
Boston Scientific's Return on Invested Capital Insights - Boston Scientific - Benzinga

According to Benzinga Pro, during Q3, Boston Scientific BSX earned $188.00 million, a 27.69% increase from the preceding quarter. Boston Scientific's sales decr...

Boston Scientific's Return on Invested Capital Insights - Boston Scientific - Benzinga
MarketWatch 5d
Buy-rated Boston Scientific's $615 million takeover of Apollo Endosurgery is a positive, says Needham

Boston Scientific Corp.'s BSX, +0.82% $615 million acquisition of Apollo Endosurgery Inc. APEN, +65.25% announced earlier is complementary to the former's endos...

Buy-rated Boston Scientific's $615 million takeover of Apollo Endosurgery is a positive, says Needham
MarketWatch 5d
Apollo Endosurgery Shares Hit 52-Week High on Boston Scientific Deal >APEN - MarketWatch

By Colin Kellaher Shares of Apollo Endosurgery Inc. surged to a 52-week high on Tuesday after the medical-technology company agreed to be acquired by Boston Sc...

Apollo Endosurgery Shares Hit 52-Week High on Boston Scientific Deal >APEN - MarketWatch

Analyst ratings

89%

of 28 ratings
Buy
89.3%
Hold
10.7%
Sell
0%

BSX Earnings

$0.00
$0.15
$0.30
$0.45
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 1, Pre-Market
ActualExpected Feb 1, Pre-Market

More BSX News

Reuters 5d
Boston Scientific to buy Apollo Endosurgery for $417 million - Reuters

Nov 29 (Reuters) - Boston Scientific Corporation (BSX.N) said on Tuesday it will buy medical technology firm Apollo Endosurgery Inc (APEN.O) for $...

Boston Scientific to buy Apollo Endosurgery for $417 million - Reuters
Yahoo Finance 5d
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc. - Yahoo Finance

Acquisition to expand endoluminal surgery portfolio and add differentiated technologies for endobariatric procedures MARLBOROUGH, Mass., Nov. 29, 2022 /PRNewsw...

Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc. - Yahoo Finance
Yahoo Finance 5d
Bifurcation Lesions Global Market Report 2022: Ukraine-Russia War Impact - Yahoo Finance

ReportLinker Major players in the bifurcation lesions market are Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics, Medtronic, Cardinal...

Bifurcation Lesions Global Market Report 2022: Ukraine-Russia War Impact - Yahoo Finance
Benzinga 6d
Golden Cross Appears Before Boston Scientific Investors - Boston Scientific - Benzinga

If history is any guide, there may be good fortune ahead for shares of Boston Scientific BSX. A so-called "golden cross" has formed on its chart and, not surpri...

Golden Cross Appears Before Boston Scientific Investors - Boston Scientific - Benzinga
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.